Replies to post #430056 on NorthWest Biotherapeutics Inc (NWBO)

[dennisdave]

the challenge is not only the production capacity after approval the challenge is first and foremost getting all countries/insurances companies in a reasonable amount of time ready to reimburse approved DCVX L.

This is something that a Merck will be able to do blindfolded and NWBO has not even start to begin to think about thinking about.